Please assess the completion status of the following clinical trial:

Trial Title: A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* between the age of 18-49 years, is willing to use LNG 1.5 mg tablets as her primary contraceptive method, wants to avoid pregnancy for at least the next 6 months after enrollment, is willing to accept an uncertain risk of pregnancy during the study, and understands that the risk of pregnancy on this method would be slightly higher than other methods of contraception~Exclusion Criteria:~* women using one or more of the following contraceptive methods: daily pill, injectable, implant, sterilization

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).